{"id":808978,"date":"2025-02-05T07:03:38","date_gmt":"2025-02-05T12:03:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/"},"modified":"2025-02-05T07:03:38","modified_gmt":"2025-02-05T12:03:38","slug":"perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/","title":{"rendered":"Perspective Therapeutics to Participate in Upcoming February Investor Conferences"},"content":{"rendered":"
\n

SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming investor conferences.<\/p>\n

\n Oppenheimer’s 35th Annual Healthcare Life Sciences Conference \u2013 Fireside Chat<\/strong>
\n
\n Date:<\/strong> Wednesday, February 12, 2025
Time:<\/strong> 2:00 p.m. – 2:30 p.m. ET
Location:<\/strong> Virtual<\/p>\n

\n B. Riley Securities Precision Oncology & Radiopharma Investor Conference <\/strong>
\n
\n Date:<\/strong> Friday, February 28, 2025
Location:<\/strong> New York, NY<\/p>\n

Webcast events can be accessed live, and replays will be archived for 90 days and available through the Investors page on the Perspective website at https:\/\/perspectivetherapeutics.com\/investor-center.<\/p>\n

\n About Perspective Therapeutics, Inc.<\/strong>
\n
Perspective Therapeutics, Inc., is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha emitting isotope\u00a0212<\/sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moeities. The Company is also developing complementary imaging diagnostics that incorporate the same targeting moeities which provide the opportunity to personalize treatment and optimize patient outcomes. This “theranostic” approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity.<\/p>\n

The Company’s melanoma (VMT01) and neuroendocrine tumor (VMT-\u03b1-NET) programs have entered Phase 1\/2a imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at several leading academic institutions. The Company has also developed a proprietary\u00a0212<\/sup>Pb generator to secure key isotopes for clinical trial and commercial operations.<\/p>\n

For more information, please visit the Company’s website at\u00a0www.perspectivetherapeutics.com<\/a>.<\/p>\n

\n Safe Harbor Statement<\/strong>
\n
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include statements concerning, among other things, the Company’s ability to pioneer advanced treatment applications for cancers throughout the body; the ability of the Company’s proprietary technology utilizing the alpha emitting isotope\u00a0212<\/sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moeities; the Company’s prediction that complementary imaging diagnostics that incorporate certain targeting moeities provide the opportunity to personalize treatment and optimize patient outcomes; the Company’s belief that its “theranostic” approach enables the ability to see a specific tumor and then treat it to potentially improve efficacy and minimize toxicity; the Company’s ability to develop a proprietary\u00a0212<\/sup>Pb generator to secure key isotopes for clinical trial and commercial operations; and other statements that are not historical fact.<\/p>\n

These forward-looking statements involve risks and uncertainties that could cause the Company’s actual results to differ materially from the results described in or implied by the forward-looking statements. Certain factors that may cause the Company’s actual results to differ materially from those expressed or implied in the forward-looking statements in this press release are described under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), in the Company’s other filings with the SEC, and in the Company’s future reports to be filed with the SEC and available at www.sec.gov. Forward-looking statements contained in this news release are made as of this date. Unless required to do so by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.<\/p>\n

\n Media and Investor Relations Contacts:<\/strong>\n <\/p>\n

\n Perspective Therapeutics IR:<\/strong>
\n
Annie J. Cheng, CFA
ir@perspectivetherapeutics.com<\/a><\/p>\n

\n Russo Partners, LLC<\/strong>
\n
Nic Johnson
PerspectiveIR@russopr.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming investor conferences. Oppenheimer’s 35th Annual Healthcare Life Sciences Conference \u2013 Fireside Chat Date: Wednesday, February 12, 2025Time: 2:00 p.m. – 2:30 p.m. ETLocation: Virtual B. Riley Securities Precision Oncology & Radiopharma Investor Conference Date: Friday, February 28, 2025Location: New York, NY Webcast events can be accessed live, and replays will be archived for 90 days and available through the Investors page on the Perspective website … <\/p>\n

Continue reading “Perspective Therapeutics to Participate in Upcoming February Investor Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-808978","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPerspective Therapeutics to Participate in Upcoming February Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Perspective Therapeutics to Participate in Upcoming February Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming investor conferences. Oppenheimer’s 35th Annual Healthcare Life Sciences Conference \u2013 Fireside Chat Date: Wednesday, February 12, 2025Time: 2:00 p.m. – 2:30 p.m. ETLocation: Virtual B. Riley Securities Precision Oncology & Radiopharma Investor Conference Date: Friday, February 28, 2025Location: New York, NY Webcast events can be accessed live, and replays will be archived for 90 days and available through the Investors page on the Perspective website … Continue reading "Perspective Therapeutics to Participate in Upcoming February Investor Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T12:03:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzE3MSM2NzM2MDIyIzUwMDAyODY4Mw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Perspective Therapeutics to Participate in Upcoming February Investor Conferences\",\"datePublished\":\"2025-02-05T12:03:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/\"},\"wordCount\":604,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzE3MSM2NzM2MDIyIzUwMDAyODY4Mw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/\",\"name\":\"Perspective Therapeutics to Participate in Upcoming February Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzE3MSM2NzM2MDIyIzUwMDAyODY4Mw==\",\"datePublished\":\"2025-02-05T12:03:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzE3MSM2NzM2MDIyIzUwMDAyODY4Mw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzE3MSM2NzM2MDIyIzUwMDAyODY4Mw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Perspective Therapeutics to Participate in Upcoming February Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Perspective Therapeutics to Participate in Upcoming February Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Perspective Therapeutics to Participate in Upcoming February Investor Conferences - Market Newsdesk","og_description":"SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming investor conferences. Oppenheimer’s 35th Annual Healthcare Life Sciences Conference \u2013 Fireside Chat Date: Wednesday, February 12, 2025Time: 2:00 p.m. – 2:30 p.m. ETLocation: Virtual B. Riley Securities Precision Oncology & Radiopharma Investor Conference Date: Friday, February 28, 2025Location: New York, NY Webcast events can be accessed live, and replays will be archived for 90 days and available through the Investors page on the Perspective website … Continue reading \"Perspective Therapeutics to Participate in Upcoming February Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-05T12:03:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzE3MSM2NzM2MDIyIzUwMDAyODY4Mw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Perspective Therapeutics to Participate in Upcoming February Investor Conferences","datePublished":"2025-02-05T12:03:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/"},"wordCount":604,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzE3MSM2NzM2MDIyIzUwMDAyODY4Mw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/","name":"Perspective Therapeutics to Participate in Upcoming February Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzE3MSM2NzM2MDIyIzUwMDAyODY4Mw==","datePublished":"2025-02-05T12:03:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzE3MSM2NzM2MDIyIzUwMDAyODY4Mw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzE3MSM2NzM2MDIyIzUwMDAyODY4Mw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/perspective-therapeutics-to-participate-in-upcoming-february-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Perspective Therapeutics to Participate in Upcoming February Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/808978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=808978"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/808978\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=808978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=808978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=808978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}